We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

86 hedge funds and large institutions have $170M invested in VanEck Biotech ETF in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

9% more funds holding

Funds holding: 79 → 86 (+7)

6% more capital invested

Capital invested by funds: $161M → $170M (+$9.23M)

3.18% more ownership

Funds ownership: 26.4% → 29.58% (+3.2%)

7% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 27

82% less call options, than puts

Call options by funds: $1.78M | Put options by funds: $10.1M

Holders
86
Holders Change
+7
Holders Change %
+8.86%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
25
Reduced
27
Closed
7
Calls
$1.78M
Puts
$10.1M
Net Calls
-$8.33M
Net Calls Change
-$13.3M

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$6.24M
2
CG
Colony Group
Massachusetts
+$4.85M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.56M
4
Bank of America
Bank of America
North Carolina
+$2.45M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.25M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$4.89M
2
TH
Timber Hill
Connecticut
-$2.25M
3
BPC
Banque Pictet & Cie
Switzerland
-$1.77M
4
Millennium Management
Millennium Management
New York
-$1.29M
5
Jane Street
Jane Street
New York
-$1.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFG
76
Next Financial Group
Texas
$19K – – –
US Bancorp
77
US Bancorp
Minnesota
$16K -$2.94K -27 -15%
Envestnet Asset Management
78
Envestnet Asset Management
Illinois
$16K +$15.7K +144 New
MIFH
79
Migdal Insurance & Financial Holdings
Israel
$16K +$16.4K +151 New
Simplex Trading
80
Simplex Trading
Illinois
$15K +$1.2K +11 +9%
Thrivent Financial for Lutherans
81
Thrivent Financial for Lutherans
Minnesota
$14K +$13.1K +120 New
BC
82
Barnett & Company
Tennessee
$11K – – –
AIP
83
Ameritas Investment Partners
Nebraska
$5K -$8.7K -80 -62%
QAM
84
QCI Asset Management
New York
$3K +$2.72K +25 New
MFW
85
Mosaic Family Wealth
Missouri
$1K – – –
Millennium Management
86
Millennium Management
New York
– -$1.29M -11,160 Closed
Truist Financial
87
Truist Financial
North Carolina
– -$734K -6,368 Closed
Citadel Advisors
88
Citadel Advisors
Florida
– -$725K -6,295 Closed
BRWA
89
B. Riley Wealth Advisors
Florida
– -$337K -2,926 Closed
FAAS
90
First Allied Advisory Services
California
– -$331K -2,869 Closed
CLOS
91
Compagnie Lombard Odier SCmA
Switzerland
– -$92K -800 Closed
Mariner
92
Mariner
Kansas
– -$35K -300 Closed
1 2 3
4

BBH Hedge Fund Activity: Q4 2016 in Review

86 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2016, worth a combined $170M — up 5.7% from $161M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BBH positions and 7 closed out — a net gain of 10 holders — while 25 added to existing stakes and 27 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $6.24M. The largest seller was Goldman Sachs, cutting an estimated $4.89M.

  • 86 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2016, up from 79 in Q3 2016.
  • Funds reported $170M of VanEck Biotech ETF stock for Q4 2016, up 5.7% quarter-over-quarter.
  • 17 funds opened new VanEck Biotech ETF positions in Q4 2016 and 7 closed out, a net change of +10 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2016 was AllianceBernstein, an estimated $6.24M added.
  • The largest VanEck Biotech ETF seller in Q4 2016 was Goldman Sachs, an estimated $4.89M sold.

Based on aggregated 13F filings for Q4 2016.